Comparative evaluation of the new GRPR-antagonist In-111-SB9 and In-111-AMBA in prostate cancer models: Implications of in vivo stability

E Lymperis; A Kaloudi; P Kanellopoulos; Eric Krenning; Marion Jong; T Maina; BA Nock

doi:10.1002/jlcr.3733

Comparative evaluation of the new GRPR-antagonist In-111-SB9 and In-111-AMBA in prostate cancer models: Implications of in vivo stability

E Lymperis, A Kaloudi, P Kanellopoulos, Eric Krenning, Marion Jong, T Maina, BA Nock

Radiology & Nuclear Medicine

Research output: Contribution to journal › Article › Academic › peer-review

13 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	646-655
Number of pages	10
Journal	Journal of Labelled Compounds & Radiopharmaceuticals
Volume	62
Issue number	10
DOIs	https://doi.org/10.1002/jlcr.3733
Publication status	Published - 2019

Research programs

EMC MM-01-40-01

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/jlcr.3733

http://hdl.handle.net/1765/117421

Cite this

@article{7f7fe69df37244039d5ba5fdd1072819,

title = "Comparative evaluation of the new GRPR-antagonist In-111-SB9 and In-111-AMBA in prostate cancer models: Implications of in vivo stability",

author = "E Lymperis and A Kaloudi and P Kanellopoulos and Eric Krenning and Marion Jong and T Maina and BA Nock",

year = "2019",

doi = "10.1002/jlcr.3733",

language = "Undefined/Unknown",

volume = "62",

pages = "646--655",

journal = "Journal of Labelled Compounds \& Radiopharmaceuticals",

issn = "0362-4803",

publisher = "John Wiley \& Sons Ltd.",

number = "10",

}

TY - JOUR

T1 - Comparative evaluation of the new GRPR-antagonist In-111-SB9 and In-111-AMBA in prostate cancer models: Implications of in vivo stability

AU - Lymperis, E

AU - Kaloudi, A

AU - Kanellopoulos, P

AU - Krenning, Eric

AU - Jong, Marion

AU - Maina, T

AU - Nock, BA

PY - 2019

Y1 - 2019

U2 - 10.1002/jlcr.3733

DO - 10.1002/jlcr.3733

M3 - Article

C2 - 30963606

SN - 0362-4803

VL - 62

SP - 646

EP - 655

JO - Journal of Labelled Compounds & Radiopharmaceuticals

JF - Journal of Labelled Compounds & Radiopharmaceuticals

IS - 10

ER -